Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia

Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect testicles. Lower testosterone levels have been associated with worse clinical outcomes and higher mortality. Our objective was to evaluate the hypothalamic–pituitary–gonadal axis of men admitted with SARS-CoV-2 p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lorenzo Marinelli, Guglielmo Beccuti, Marco Zavattaro, Serena Cagnina, Iacopo Gesmundo, Chiara Bona, Chiara Lopez, Silvia Scabini, Francesca Canta, Simone Mornese Pinna, Tommaso Lupia, Cataldo Di Bisceglie, Federico Ponzetto, Fabio Settanni, Francesco Giuseppe De Rosa, Ezio Ghigo, Giovanna Motta
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2022-03-01
Saila:Biomedicines
Gaiak:
SARS-CoV-2
COVID-19
pneumonia
testosterone
men
hypogonadism
Sarrera elektronikoa:https://www.mdpi.com/2227-9059/10/4/820
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak